✦ LIBER ✦

595 ASSOCIATION BETWEEN AMINO-ACID SEQUENCES OF HEPATITIS C VIRUS (HCV) CORE, E1, AND NS5A REGIONS AND OUTCOME OF PEGINTERFERON/RIBABIRIN THERAPY IN HCV GENOTYPE 1B

✍ Scribed by T. Arakawa; H. Toyoda; T. Kumada

Book ID: 117377604
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 51 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(09)60597-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association between HCV amino acid subst

Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load

✍ Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Takahiro Arakawa; Kazuhiko Haya 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Association of amino acid variations in

Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma

✍ C.-H. Hung; C.-H. Chen; C.-M. Lee; C.-M. Wu; T.-H. Hu; J.-H. Wang; Y.-H. Yen; S. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Mutations in the NS5A and E2-PePHD regio

Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin

✍ Sheng-Shun Yang; Ming-Yang Lai; Ding-Shinn Chen; Gran-Hum Chen; Jia-Horng Kao 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

A matched case-controlled study of 48 an

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response

✍ Norio Akuta; Fumitaka Suzuki; Miharu Hirakawa; Yusuke Kawamura; Hiromi Yatsuji; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract Substitution of amino acid (aa) 70 and 91 in the core region of HCV genotype 1b is a useful pretreatment predictor of efficacy of 48‐week peginterferon (PEG‐IFN) plus ribavirin (RBV) therapy. Here, we determined the efficacy of 72‐week PEG‐IFN/RBV and the predictive factors to such ther

Mutations in the core and NS5A region of

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

✍ K. Hayashi; Y. Katano; M. Ishigami; A. Itoh; Y. Hirooka; I. Nakano; F. Urano; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

621 THE ROLE OF SUBSTITUTIONS IN THE COR

621 THE ROLE OF SUBSTITUTIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B ON RESPONSIVENESS TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY

✍ Y. Katano; M. Ishigami; I. Nakano; K. Hayashi; T. Honda; H. Goto 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB